Current and emerging therapies for the treatment of myasthenia gravis
Renato Mantegazza, Silvia Bonanno, Giorgia Camera, Carlo AntozziDepartment of Neuromuscular Diseases and Neuroimmunology, Fondazione Istituto Neurologico Carlo Besta, Milan, ItalyAbstract: Myasthenia gravis (MG) is an autoimmmune disease in which autoantibodies to different antigens of the neuromusc...
Main Authors: | Renato Mantegazza, Silvia Bonanno, Giorgia Camera, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-03-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/current-and-emerging-therapies-for-the-treatment-of-myasthenia-gravis-a6791 |
Similar Items
-
Myasthenia Gravis
by: Johan A. Aarli, et al.
Published: (2011-01-01) -
Current and emerging treatments for the management of myasthenia gravis
by: Sathasivam S
Published: (2011-07-01) -
Complement Inhibition for the Treatment of Myasthenia Gravis
by: Mantegazza R, et al.
Published: (2020-12-01) -
When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies
by: Renato Mantegazza, et al.
Published: (2018-01-01) -
From Traditional to Targeted Immunotherapy in Myasthenia Gravis: Prospects for Research
by: Renato Mantegazza, et al.
Published: (2020-09-01)